Navigation Links
EMBO announces the launch of EMBO Press

HEIDELBERG, 29 October 2013 EMBO today announced that it will launch EMBO Press on December 15. EMBO Press is a new publishing platform for The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine that provides opportunities for the future development of the journals.

EMBO Press will strengthen the policies of the EMBO journals to encourage transparency in the publication process and help researchers make better use of scientific data. In addition, The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine are being redesigned to maximize online functionality and access.

The announcement coincides with an expanded publishing agreement with Wiley and a new partnership with HighWire Press of Stanford University that come into immediate effect.

Wiley has published EMBO Molecular Medicine since 2009. As one of the world's leading publishers of academic content, it will provide invaluable support for editorial production and international marketing of the four EMBO scientific journals.

HighWire Press is at the forefront of digital scholarly publishing. Many leading journals in the life sciences rely on its community-based strengths and its track record for technological support and innovation, including access to third party developers.

"We welcome our publishing partners to support EMBO Press and appreciate the strengths they will bring for the key global markets of our journals, including the United States and Asia Pacific," said Bernd Pulverer, Head of Scientific Publications at EMBO. "Our individual journals already have strong recognition for quality in the scientific community established over 30 years since the launch of The EMBO Journal and our mandate is to serve the scientific community. EMBO Press will allow us to provide the independence we need to ensure that the EMBO Press portfolio of journals stay at the forefront of technological advances and delivers the best possible service to the research community. In particular, it will allow EMBO to continue our commitment to the principles of transparent, fast and fair publication in the life sciences while maintaining our reputation for selectivity and quality."

EMBO Press will include enhanced options for publishing source data, and rendering the data presented in figures more usable and discoverable. Researchers will be able to customize and optimize their reader experience. Restructuring the way papers are presented will obviate the need for a separate supplementary information section.

"Many exciting developments lie ahead in publishing and we want to have a platform that supports technological responsiveness and high-level support," added Pulverer. "Access to the Drupal tools integrated into the HighWire Press Open Platform creates new possibilities for innovation in areas like data presentation, semantic interlinking, article level metrics and mobile web interfaces. There will be many exciting technological developments in the future and we want our authors and readers to be in a position to benefit."

"After many years of fruitful collaboration with Nature Publishing Group, we have decided to collaborate with Wiley and HighWire to implement the EMBO Press platform. EMBO Press gives us the freedom and flexibility we need to realize our future plans for the journals," commented Maria Leptin, Director of EMBO. "All the financial benefits from our publishing activities will continue to support the activities of EMBO and the scientific community."


Contact: Barry Whyte
European Molecular Biology Organization

Related biology news :

1. Basis Extends Series B to more than $23 Million; Announces Mobile Veteran, Ethan Fassett, as VP of Product
2. Biocom Announces 2013 San Diego Mayoral Primary Endorsement
3. Trovagene Announces Abstracts to be Presented at Molecular Targets and Cancer Therapeutics Conference
4. Dr. Bradley Kurgis Announces Free Skin Rejuvenation Consultation
5. Extreme Peptide Announces that its EP Reward Points Program is Now Easier than Ever to Use
6. Prostate Cancer Foundation announces new urine test for prostate cancer available
7. EcoHealth Alliance announces new award from USAID to combat disease emergence and climate change
8. NIH announces awards to strengthen the biomedical research workforce
9. New York Genome Center announces the New York Stem Cell Foundation as an Associate Member
10. DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
11. Entomological Society of America announces 2013 awardees
Post Your Comments:
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: